Alex Goldberg

OTC Gainers Watch List: Creative Edge Nutrition, Inc. (OTC:FITX) and Medical Marijuana, Inc. (OTC:MJNA) Added to Equity Profile Report's OTC Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/13/2014 -- Equity Profile Report expands its OTC Gainers Weekly Watch List adding Creative Edge Nutrition, Inc. (OTC:FITX) and Medical Marijuana, Inc. (OTC:MJNA).

Creative Edge Nutrition, Inc. (OTC:FITX) a nutritional supplement company that develops, markets, and sells nutraceuticals and health supplements is currently up (+11.32%) on 138,717,486 shares traded after Creative Edge Nutrition Inc. announced that it was the subject of a feature story in Crain’s Detroit Business Magazine. With this recent news this has prompted Equity Profile Report to add the stock to their OTC Gainers Watch List.

Click Here to find out what other Investors are saying about Creative Edge Nutrition, Inc. (OTC:FITX)

Medical Marijuana, Inc. (OTC:MJNA) a company that operates in the medical marijuana and industrial hemp markets is currently up (+3.19%) on 13,488,876 shares traded after Medical Marijuana Inc.'s HempMedsPX Announced Availability of New Cibdex Cannabidiol Rich Hemp Oil in Vegan Capsules. Medical Marijuana, Inc. (OTC:MJNA) is currently up (+133.33%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their OTC Gainers Watch List.

Click Here to find out what other Investors are saying about Medical Marijuana, Inc. (OTC:MJNA)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com